Raysen Biotech Group-B (02179): Electing Xu Haoyu as Chairman of the Board

The Intelligent Financial APP News, Regeneus-B (02179) issued an announcement, the Board of Directors received Dr. Liu Yong's resignation report on December 22, 2025. In order to further enhance the company's governance level and to devote more time to other work, Dr. Liu Yong resigned as Chairman of the Board of Directors and Chairman of the Nomination Committee of the Board of Directors, effective from the date when the new Chairman of the Board of Directors is elected. Dr. Liu Yong will continue to serve as the company's Executive Director and General Manager, overseeing the company's overall production and operations management. The Board of Directors is pleased to announce that at the Board of Directors meeting held on December 23, 2025, Mr. Xu Haoyu was elected as the Chairman of the Second Board of Directors of the company, with a term from the date of approval by the Board of Directors until the expiration of the term of the Second Board of Directors.